| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 08/02/2011 | US7989605 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 08/02/2011 | US7989475 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 08/02/2011 | CA2668311C Enhancing photodamage caused by ultraviolet light using a 3-hydroxypyridine analog |
| 08/02/2011 | CA2542105C Compounds and compositions as protein kinase inhibitors |
| 08/02/2011 | CA2523859C Methods and devices for the sustained release of multiple drugs |
| 08/02/2011 | CA2503196C Compositions that treat or inhibit pathological conditions associated with inflammatory response |
| 08/02/2011 | CA2427964C Method and preparations having effect against allergic symptoms |
| 07/28/2011 | US20110184069 Methods and compositions for administration of trpv1 agonists |
| 07/28/2011 | US20110182900 Compositions and methods for treating coagulation related disorders |
| 07/27/2011 | EP2348135A2 Identification of surface-associated antigenes used for the diagnosis and therapy of tumours |
| 07/27/2011 | EP2348103A2 Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
| 07/27/2011 | EP2347767A2 Immune regulation based on the targeting of early activation molecules |
| 07/27/2011 | EP1691761B1 A low-weight ultra-thin flexible radiation attenuation composition |
| 07/27/2011 | EP1578439B1 Low dose methods for treating disorders in which tnf-alpha activity is detrimental |
| 07/27/2011 | EP1419152B1 Hiv inhibiting pyrimidines derivatives |
| 07/27/2011 | EP1125585B1 Treatment of graft-versus-host disease targeting ailim |
| 07/26/2011 | US7985845 Protein formulation |
| 07/26/2011 | CA2268331C Treatment of inner ear hair cells |
| 07/21/2011 | US20110178488 Sexual Hygienic Composition |
| 07/21/2011 | US20110178014 Prevention and treatment of cardiac arrhythmias |
| 07/21/2011 | US20110177110 Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof |
| 07/20/2011 | EP2345735A1 Xanthomonas campestris with multiple copies of gumB and gumC |
| 07/20/2011 | EP1496891B1 Methods for modulating phototoxicity |
| 07/20/2011 | EP1317279B1 Vaccine against streptococcus pneumoniae |
| 07/20/2011 | CN1951965B Glp-1衍生物 Glp-1 derivatives |
| 07/20/2011 | CN1917896B Surface protection of exposed biological tissues |
| 07/20/2011 | CN102125557A Use of flibanserin in the treatment of sexual disorders |
| 07/19/2011 | US7982037 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3 |
| 07/19/2011 | US7982034 Prodrugs of heteroaryl compounds |
| 07/19/2011 | US7982015 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/19/2011 | US7981881 Fused heterocyclic compounds and use thereof |
| 07/19/2011 | US7981435 Spill resistant formulations containing clays |
| 07/19/2011 | CA2634702C Crystalline and pure modafinil, and process of preparing the same |
| 07/19/2011 | CA2509035C Contrast media formulations having improved biological tolerance |
| 07/19/2011 | CA2448561C Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 07/19/2011 | CA2341441C Methods of using and compositions comprising dopamine reuptake inhibitors |
| 07/19/2011 | CA2336445C Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 07/13/2011 | EP2343290A1 Diamine derivatives as factor X inhibitors |
| 07/13/2011 | CN102120031A Pharmaceutical compositions and methods for accelerating wound healing |
| 07/12/2011 | US7977455 Analogues of GLP-1 |
| 07/12/2011 | US7977366 Treating an inflammatory disorder or inhibiting respiratory burst in adherent neutrophils with chemical inhibitors of neutrophil activation |
| 07/12/2011 | US7977357 Polymorphic forms of 3-(4-amino-1-oxo-1, 3 dihydro-isoindo1-2-yl)-piperidine-2,6-dione |
| 07/12/2011 | US7977337 Quinoline derivatives and their use as 5-HT6 ligands |
| 07/12/2011 | CA2526534C Compounds and methods for delivery of prostacyclin analogs |
| 07/12/2011 | CA2516699C Hiv replication inhibiting pyrimidines and triazines |
| 07/07/2011 | US20110166114 Method for treating snoring and sleep apnea with leukotriene antagonists |
| 07/07/2011 | US20110166084 Controlled release composition and method of producing the same |
| 07/07/2011 | US20110165234 Extended release venlafaxine formulation |
| 07/07/2011 | US20110165177 Methods of Modulating Immunity |
| 07/07/2011 | US20110165071 Methods Of Treating Cancer |
| 07/06/2011 | EP2341080A1 Humanized immunoglobulins and their production and use |
| 07/06/2011 | EP2340833A2 Controlled release oxycodone compositions |
| 07/06/2011 | EP1643984B1 Use of parthenolide derivatives as antileukemic and cytotoxic agents |
| 07/06/2011 | EP1587834B1 Uses of il-23 mammalian cytokine; related reagents |
| 07/06/2011 | CN1871034B Methods and compositions for cancer therapy using a novel adenovirus |
| 07/06/2011 | CN1705662B Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B |
| 07/06/2011 | CN101357915B Diazabicyclic central nervous system active agents |
| 07/05/2011 | US7973052 Compounds for the treatment of metabolic disorders |
| 07/05/2011 | US7972603 Stable immunogenic product comprising antigenic heterocomplexes |
| 07/05/2011 | CA2540200C Topical composition containing porous spherical disintegrative silica impregnated with water-insoluble skin benefit agent |
| 07/05/2011 | CA2504886C Synthetic lactone formulations and method of use |
| 06/30/2011 | US20110160440 Cab Molecules |
| 06/30/2011 | US20110160246 Neurodegenerative Protein Aggregation Inhibition Methods and Compounds |
| 06/30/2011 | US20110159082 Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
| 06/30/2011 | US20110158986 Humanized antibodies that sequester amyloid beta peptide |
| 06/30/2011 | US20110158952 Compositions and methods for treating human papillomavirus-mediated disease |
| 06/30/2011 | US20110158937 Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy |
| 06/29/2011 | EP2338508A1 A rDEN3/4delta 30(ME), rDEN2/4delta30(ME) or rDEN1/4delta30(ME) recombinant chimeric dengue virus containing a 30 nucleotide deletion (delta30) in a section of the 3' untranslated region of dengue type 4 genome, wherein said 30 nucleotide deletion corresponds to the TL2 stem-loop structure. |
| 06/29/2011 | CN1863923B Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases |
| 06/29/2011 | CN101049502B Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases |
| 06/28/2011 | US7968752 Hydrolytically-resistant boron-containing therapeutics and methods of use |
| 06/28/2011 | US7968511 Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis |
| 06/28/2011 | US7968089 Proteoglycan degrading mutants for the treatment of CNS |
| 06/28/2011 | CA2526562C Carbostyril derivatives and mood stabilizers for treating mood disorders |
| 06/28/2011 | CA2467672C Chemokine receptor antagonists and methods of use therefor |
| 06/28/2011 | CA2377909C Pharmaceutical composition containing fenofibrate and preparation method |
| 06/23/2011 | WO2011075179A1 Automated treatment system for sleep |
| 06/23/2011 | US20110152359 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising threreof |
| 06/23/2011 | US20110152335 Allantoin-containing skin cream |
| 06/23/2011 | US20110151022 Thiotungstate analogues and uses thereof |
| 06/23/2011 | US20110150911 Methods and reagents for treating, preventing and diagnosing bunyavirus infection |
| 06/23/2011 | US20110150863 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 06/23/2011 | CA2783015A1 Automated treatment system for sleep |
| 06/22/2011 | EP2336184A2 Administration of agents for the treatment of inflammation |
| 06/22/2011 | EP2336182A1 Treatment of TNF alpha related disorders |
| 06/22/2011 | EP2336168A1 Novel protein and method for producing the protein |
| 06/22/2011 | EP1619951B1 Methods and compositions for treating disorders |
| 06/22/2011 | CN1835723B Deployable multifunctional hemostatic agent |
| 06/21/2011 | US7964622 Indole acetic acid derivatives and their use as pharmaceutical agents |
| 06/21/2011 | US7964609 Use of mGluR5 antagonists for the treatment of gerd |
| 06/21/2011 | US7964568 Synthesis of high molecular weight iron-saccharidic complexes |
| 06/21/2011 | CA2505786C Methods for identifying risk of breast cancer and treatments thereof |
| 06/21/2011 | CA2499273C Inhalation compositions |
| 06/21/2011 | CA2474192C Nicotinamide derivates useful as p38 inhibitors |
| 06/16/2011 | US20110144072 Antiglucocorticoid Therapy for the Prevention of Neurological Damage in Premature Infants |
| 06/16/2011 | US20110144042 Novel Polysaccharides with Antithrombotic Activity Comprising at Least One Covalent Bond with Biotin or a Biotin Derivative |
| 06/16/2011 | US20110144020 Treatment of infections and other disorders |
| 06/16/2011 | US20110144008 Peptide agonists of glp-1 activity |
| 06/16/2011 | US20110142823 Humanized antibodies that recognize beta amyloid peptide |
| 06/15/2011 | EP2333069A2 Therapeutic uses of IL-17 homologous polypeptides |